CRISPR THERAPEUTICS AG Investment Income, Interest
CRISPR THERAPEUTICS AG (CRSP) reported Investment Income, Interest of $104.30 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-11.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2025-02-11
- CRISPR THERAPEUTICS AG investment income, interest for fiscal 2024 was $104.30M, a 36.52% increase from fiscal 2023.
- CRISPR THERAPEUTICS AG investment income, interest for fiscal 2023 was $76.40M, a 227.90% increase from fiscal 2022.
- CRISPR THERAPEUTICS AG investment income, interest for fiscal 2022 was $23.30M.
| Period end | Investment Income, Interest 12 month |
|---|---|
| 2024-12-31 | $104.30M 10-K · filed 2025-02-11 |
| 2023-12-31 | $76.40M 10-K · filed 2025-02-11 |
| 2022-12-31 | $23.30M 10-K · filed 2025-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |